- Home
- HTGC vs BHVN Comparison
HTGC vs BHVN Comparison
Compare HTGC & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HTGC | BHVN |
|---|---|---|
| Founded | 2003 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 1.1B |
| IPO Year | 2005 | 2017 |
Fundamental Metrics
Financial Performance| Metric | HTGC | BHVN |
|---|---|---|
| Price | $18.64 | $9.62 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 15 |
| Target Price | $21.13 | ★ $29.79 |
| AVG Volume (30 Days) | 1.1M | ★ 3.2M |
| Earning Date | 02-12-2026 | 11-10-2025 |
| Dividend Yield | ★ 9.98% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.75 | N/A |
| Revenue | ★ $516,847,000.00 | N/A |
| Revenue This Year | $8.95 | N/A |
| Revenue Next Year | $9.64 | $1,147.70 |
| P/E Ratio | $10.75 | ★ N/A |
| Revenue Growth | ★ 4.54 | N/A |
| 52 Week Low | $15.65 | $7.48 |
| 52 Week High | $22.04 | $44.28 |
Technical Indicators
Market Signals| Indicator | HTGC | BHVN |
|---|---|---|
| Relative Strength Index (RSI) | 53.18 | 42.30 |
| Support Level | $18.69 | $8.50 |
| Resistance Level | $19.03 | $11.72 |
| Average True Range (ATR) | 0.23 | 0.93 |
| MACD | -0.02 | -0.05 |
| Stochastic Oscillator | 45.14 | 35.87 |
Price Performance
Historical ComparisonAbout HTGC Hercules Capital Inc.
Hercules Capital Inc is a specialty finance company that provides senior secured loans to high-growth, venture capital-backed companies in various technology, life sciences, and sustainable and renewable technology industries. It invests majorly in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The company lends to and invests in portfolio companies in various technology-related industries, including technology, drug discovery and development, biotechnology, life sciences, healthcare, and sustainable and renewable technology.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.